| Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD) (NCT05459701) | Rehab Werida | 2022-05-01 |
| Observational Study About Patients Diagnosed With NAFLD (NCT05625750) | Xiangya Hospital of Central South University | 2022-04-27 |
| Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease (NCT05330923) | Peking Union Medical College Hospital | 2022-01-01 |
| The University of Michigan Wellness for Liver Health Study (NCT05010070) | University of Michigan | 2021-08-31 |
| A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001) (NCT04944992) | Merck Sharp & Dohme LLC | 2021-08-04 |
| Time Restricted Feeding on Nonalcoholic Fatty Liver Disease ( TREATY-FLD )：a 12-month Follow-up Study (NCT04988230) | Nanfang Hospital, Southern Medical University | 2021-07-30 |
| FM101 Efficacy Study in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis (NCT04710524) | Future Medicine | 2021-06-10 |
| Gut Microbiota in Chronic Noncommunicable Diseases (NCT04820556) | National Medical Research Center for Therapy and Preventive Medicine | 2021-04-12 |
| Effects of Febuxostat for Lowering Uric Acid in NAFLD Patients With Gout (NCT04772352) | Ningbo No. 1 Hospital | 2021-03-01 |
| A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Fatty Liver Disease (NCT04766476) | Bristol-Myers Squibb | 2021-02-24 |
| Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis (NCT04399538) | Pfizer | 2020-08-10 |
| Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) (NCT04321031) | Pfizer | 2020-06-15 |
| Comparison of Dietary Sugar Reduction Methods (NCT04186793) | Emory University | 2020-02-06 |
| Effect of Mediterranean Diet in Obese Adolescents With Nonalcoholic Fatty Liver Disease (NCT04845373) | Gazi University | 2020-01-05 |
| Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD (NCT05523648) | Sichuan Leshan Traditional Chinese Medicine Hospital | 2020-01-05 |
| Evaluation of the Effects of a Low Free Sugar Diet in Patients With Nonalcoholic Fatty Liver Disease (NCT04369521) | National Nutrition and Food Technology Institute | 2019-10-23 |
| Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease (NCT04132440) | M.D. Anderson Cancer Center | 2019-08-22 |
| Time Restricted Feeding on Nonalcoholic Fatty Liver Disease (NCT03786523) | Nanfang Hospital, Southern Medical University | 2019-04-19 |
| De Novo Lipogenesis in Severity of NAFLD (NCT03683589) | University of Missouri-Columbia | 2019-02-01 |
| The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NASH (Nonalcoholic Steatohepatitis) Subjects (NCT06044467) | ChemomAb Ltd. | 2018-12-11 |
| A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM) (NCT03656744) | HighTide Biopharma Pty Ltd | 2018-11-26 |
| Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease (NCT04988204) | Icahn School of Medicine at Mount Sinai | 2018-10-03 |
| An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function (NCT03674476) | Bristol-Myers Squibb | 2018-09-11 |
| A Phase 1a/1b Study of CB4211 in Healthy Non-obese Subjects and Subjects With Nonalcoholic Fatty Liver Disease (NCT03998514) | CohBar, Inc. | 2018-07-09 |
| Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease (NCT03434613) | Yonsei University | 2018-05-14 |
| Association Between Nonalcoholic Fatty Liver Disease and Acute Pancreatitis (NCT03566173) | Ningbo No. 1 Hospital | 2018-03-10 |
| A Study of Experimental Medication BMS-986036 Given to Healthy Participants (NCT03445208) | Bristol-Myers Squibb | 2018-02-14 |
| Effectiveness of Exercise Applications on Hepatic Steatosis and Physical Fitness in Patients With NAFLD (NCT03461562) | Okan University | 2018-01-05 |
| Therapeutic Effects of Compound Zhenzhu Tiaozhi Capsules in NAFLD (NCT03375580) | The First Affiliated Hospital of Guangdong Pharmaceutical University | 2017-12-31 |
| Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) (NCT03248882) | Pfizer | 2017-08-22 |
| Effects of Exercise on Patients With Nonalcoholic Fatty Liver Disease- A Comparative Randomized Controlled Trial (NCT03774511) | Ahlia University | 2017-07-09 |
| Effects of Fructose Restriction on Liver Steatosis (NCT03067428) | Maastricht University Medical Center | 2017-01-31 |
| Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease (NCT02863757) | Humanity and Health Research Centre | 2016-08-01 |
| NASH: Non-invasive Diagnostic Markers and Imaging (NCT02717000) | Maastricht University Medical Center | 2016-04-01 |
| Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy (NCT02684591) | University of California, San Diego | 2016-01-01 |
| Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver Fibrosis (NCT03386890) | Beijing Friendship Hospital | 2015-12-01 |
| Dietary Treatment Study of Pediatric NAFLD (NCT02513121) | University of California, San Diego | 2015-07-01 |
| Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver Disease (NCT02422238) | Maastricht University Medical Center | 2015-06-01 |
| Fecal Microbiota Transplantation (FMT) in Nonalcoholic Steatohepatitis(NASH). A Pilot Study (NCT02469272) | Lifespan | 2015-05-01 |
| Controlled Trial of WLS vs. CLI for Severely Obese Adolescents With NASH (NCT02412540) | Children's Hospital Medical Center, Cincinnati | 2015-04-23 |
| Fatty Liver Disease in Obese Children (NCT02117700) | Nemours Children's Clinic | 2015-04-01 |
| Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus (NCT05697991) | King Saud University | 2015-03-23 |
| Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease (NCT02132780) | Virginia Commonwealth University | 2014-05-01 |
| Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes (NCT02132442) | University of Massachusetts, Worcester | 2014-03-01 |
| Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis (NCT01934777) | Bambino Gesù Hospital and Research Institute | 2013-10-01 |
| Purified Anthocyanin and Nonalcoholic Fatty Liver Disease (NCT01940263) | Shaoguan University | 2013-06-01 |
| Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease (NCT01828528) | Sheba Medical Center | 2013-04-01 |
| Therapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) Except Cirrhosis (NCT02029586) | Yungjin Pharm. Co., Ltd. | 2013-01-01 |
| THE ASSOCIATION BETWEEN FATTY LIVER (NAFLD) DISEASE AND PCOS (NCT01735799) | Assy Nimer | 2012-11-01 |
| A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection (NCT01645852) | Dartmouth-Hitchcock Medical Center | 2012-06-01 |
| Clinical Investigation on the Effects of Bayberry Juice Treatment in Adult Subjects With Features of Fatty Liver Disease (NCT01707914) | Shaoguan University | 2012-06-01 |
| High Fructose Corn Syrup (NCT02018237) | Washington University School of Medicine | 2012-03-01 |
| Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver Disease (NCT01446276) | University of Aarhus | 2011-11-01 |
| Dietary Protein and Hepatic Fat Accumulation (NCT01354626) | Wageningen University | 2011-08-01 |
| Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes (NCT01399645) | Centre hospitalier de l'Université de Montréal (CHUM) | 2011-05-01 |
| Rifaximin in Fatty Liver Disease (NCT01355575) | Imperial College London | 2011-05-01 |
| Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT) (NCT01244503) | Virginia Commonwealth University | 2011-02-01 |
| The Contribution of Lp-PLA2 Level to the Presence of Coronary Plaques in Patients With Non Alcoholic Fatty Liver Disease (NCT01139632) | Ziv Hospital | 2010-07-01 |
| Trial of Hepaguard® in Adults With Nonalcoholic Steatohepatitis (NCT01210989) | Chinese University of Hong Kong | 2010-05-01 |
| A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis (NCT00930384) | George Washington University | 2009-11-01 |
| Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD) (NCT00983463) | Vanderbilt University | 2009-10-01 |
| Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD) (NCT00885313) | Bambino Gesù Hospital and Research Institute | 2009-03-01 |
| Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver Disease (NCT00868933) | Chinese University of Hong Kong | 2009-02-01 |
| Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and Prebiotics (NCT00870012) | Chinese University of Hong Kong | 2009-02-01 |
| Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver Disease (NCT03847116) | Ningbo No. 1 Hospital | 2009-01-01 |
| University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial) (NCT00994682) | University of Florida | 2008-12-01 |
| Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH) (NCT01208649) | Ruhr University of Bochum | 2008-07-01 |
| Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease (NCT01006889) | University of Florida | 2008-01-01 |
| Effect of Iron Depletion by Phlebotomy Plus Lifestyle Changes vs. Lifestyle Changes Alone on Liver Damage in Patients With Nonalcoholic Fatty Liver Disease With Increased Iron Stores (NCT00658164) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2007-10-01 |
| Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study (NCT00637520) | Duke University | 2007-07-01 |
| Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH) (NCT00699036) | Brooke Army Medical Center | 2007-04-01 |
| Weight Gain After Smoking Cessation and NAFLD (NCT05550688) | Ningbo No. 1 Hospital | 2007-01-01 |
| Role of Exenatide in NASH-a Pilot Study (NCT00650546) | Indiana University | 2006-08-01 |
| LAGB as a Treatment for Morbid Obesity in Adolescents (NCT01045499) | Jeffrey L Zitsman, MD | 2005-09-13 |
| Fatty Acids, Genes and Microbiota in Fatty Liver (NCT02148471) | Johane Allard | 2003-10-01 |
| Effect of Treatment With Insulin Sensitizer on Arterial Properties, Metabolic Parameters and Liver Function in Patients With Nonalcoholic Fatty Liver Disease (NCT01084486) | Wolfson Medical Center | |